The Efficacy of Drug-Eluting Stents in Women. A Window of Opportunity

JACC: Cardiovascular Interventions

Volumn 2, Issue 7, 2009, Pages 611-613

  Jacobs, Alice K ^a  

^a BOSTON MEDICAL CENTER   (United States)

Author keywords

drug eluting stents; percutaneous coronary intervention

Indexed keywords

ACUTE HEART INFARCTION; CAUSE OF DEATH; CLINICAL EFFECTIVENESS; COMORBIDITY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DISEASE; CORONARY ARTERY THROMBOSIS; CORONARY STENT; DIABETES MELLITUS; DRUG ELUTING STENT; EDITORIAL; ENDOTHELIAL DYSFUNCTION; HEART FAILURE; HUMAN; IN-STENT RESTENOSIS; INCIDENCE; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PREVALENCE; PRIORITY JOURNAL; SEX DIFFERENCE; ST SEGMENT ELEVATION;

ANGIOPLASTY, BALLOON, CORONARY; CARDIOVASCULAR AGENTS; CORONARY ARTERY DISEASE; DRUG-ELUTING STENTS; FEMALE; HUMANS; MALE; METALS; MYOCARDIAL INFARCTION; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SEX FACTORS; SIROLIMUS; STENTS; THROMBOSIS; TIME FACTORS; TREATMENT OUTCOME; WOMEN'S HEALTH;

EID: 67650642120     PISSN: 19368798     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcin.2009.06.001     Document Type: Editorial

References (20)

1. Jacobs A.K. Women, ischemic heart disease, revascularization, and the gender gap: what are we missing?. J Am Coll Cardiol 47 (2006) S63-S65
2. Akhter N., Milford-Beland S., Roe M.T., Piana R.N., Kao J., and Shroff A. Gender differences among patients with acute coronary syndromes undergoing percutaneous coronary intervention in the American College of Cardiology-National Cardiovascular Data Registry (ACC-NCDR). Am Heart J 157 (2009) 141-148
3. Lansky A.J., Hochman J.S., Ward P.A., et al. Percutaneous coronary intervention and adjunctive pharmacotherapy in women: a statement for healthcare professionals from the American Heart Association. Circulation 111 (2005) 940-953
4. Singh M., Rihal C.S., Gersh B.J., et al. Mortality differences between men and women after percutaneous coronary interventions. A 25-year, single-center experience. J Am Coll Cardiol 51 (2008) 2313-2320
5. Jacobs A.K., Johnston J.M., Haviland A., et al. Improved outcomes for women undergoing contemporary percutaneous coronary intervention: a report from the National Heart, Lung and Blood Institute Dynamic Registry. J Am Coll Cardiol 39 (2002) 1608-1614
6. Kelsey S.F., James M., Holubkov A.L., Holubkov R., Cowley M.J., and Detre K.M. Results of percutaneous transluminal coronary angioplasty in women. 1985-1986 National Heart, Lung, and Blood Institute's Coronary Angioplasty Registry. Circulation 87 (1993) 720-727
7. Watanabe C.T., Maynard C., and Ritchie J.L. Comparison of short-term outcomes following coronary artery stenting in men versus women. Am J Cardiol 88 (2001) 848-852
8. Mehilli J., Kastrati A., Dirschinger J., Bollwein H., Neumann F., and Schömig A. Differences in prognostic factors and outcomes between women and men undergoing coronary artery stenting. JAMA 284 (2000) 1799-1805
9. Lansky A.J., Pietras C., Costa R.A., et al. Gender differences in outcomes after primary angioplasty versus primary stenting with and without abciximab for acute myocardial infarction: results of the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial. Circulation 111 (2005) 1611-1618
10. Solinas E., Nikolsky E., Lansky A.J., et al. Gender-specific outcomes after sirolimus-eluting stent implantation. J Am Coll Cardiol 50 (2007) 2111-2116
11. Lansky A.J., Costa R.A., Mooney M., et al. Gender-based outcomes after paclitaxel-eluting stent implantation in patients with coronary artery disease. J Am Coll Cardiol 45 (2005) 1180-1185
12. Abbott D., Vlachos H.A., Selzer F., et al. Gender-based outcomes in percutaneous coronary intervention with drug-eluting stents (from the National Heart, Lung, and Blood Institute Dynamic Registry). Am J Cardiol 99 (2007) 626-631
13. Onuma Y., Kukreja N., Daemen J., et al. Impact of sex on 3-year outcome after percutaneous coronary intervention using bare-metal and drug-eluting stents in de-novo coronary artery disease. J Am Coll Cardiol Intv 2 (2009) 603-610
14. Jneid H., Fonarow G.C., Cannon C.P., et al. Sex differences in medical care and early death after acute myocardial infarction. Circulation 118 (2008) 2803-2810
15. Mehilli J., Kastrati A., Bollwein H., et al. Gender and restenosis after coronary artery stenting. Eur Heart J 24 (2003) 1523-1530
16. Pepine C.J., Kerensky R.A., Lambert C.R., et al. Some thoughts on the vasculaopathy of women with ischemic heart disease. J Am Coll Cardiol 47 Suppl (2006) S30-S35
17. Mikkola T., Turunen P., Avela K., et al. 17 beta-estradiol stimulates prostacyclin, but not endothelin-1, production in human vascular endothelial cells. J Clin Endocrinol Metab 80 (1995) 1832-1836
18. Chen S.J., Li H., Durand J., et al. Estrogen reduces myointimal proliferation after balloon injury of rat carotid artery. Circulation 93 (1996) 577-584
19. Anthony M., and Berg M.J. Biologic and molecular mechanisms for sex differences in pharmacokinetics, pharmacodynamics, and pharmacogenetics: Part I. J Women's Health 11 (2002) 601-615
20. Alexander K.P., Chen A.Y., Newby L.K., et al. Sex differences in major bleeding with glycoprotein IIb/IIIa inhibitors: results from the CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA guidelines) initiative. Circulation 114 (2006) 1380-1387